MedTrace Logo

A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel

NCT01787227 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2016-03-03

No results posted yet for this study

Summary

xTAG RPP assay is a PCR-based assay to detect the presence or absence of viral and bacterial DNA / RNA in clinical specimens (nasopharyngeal swabs).

The objective of this study is to establish diagnostic accuracy of the xTAG RPP.

Conditions

  • Respiratory Tract Infection
  • Bronchitis
  • Bronchiolitis
  • Pneumonia

Interventions

DEVICE

xTAG RPP

Sponsors & Collaborators

  • Luminex Molecular Diagnostics

    lead INDUSTRY

Principal Investigators

  • Jeremy Liu, Ph.D · Luminex Molecular Diagnostics

  • James Mahony, Ph.D, FCCM, FAAM · St. Joseph's Health Care London

  • Richard Buller, PhD, D (ABMM) · St. Louis Children's Hospital

  • Arundhati Rao, M.D., Ph.D. · Scott and White Hospital & Clinic

  • Christine Ginocchio, Ph.D., M.T.(A.S.C.P.) · North Shore-LIJ Health System Laboratories, NY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-09-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01787227 on ClinicalTrials.gov